|
|
 |
 |
Treatment regimens for multiple myeloma are evolving because of new advances in both pharmacotherapy and transplantation strategies. The Multiple Myeloma Research Foundation has gathered the top thought leaders in myeloma research to prepare an engaging, interactive CME webcast titled Case Studies in Multiple Myeloma.
|
 |
New Strategies in Transplantation Therapy
Jean-Luc Harousseau, MD
University of Nantes, Nantes Cedex, France
|
 |
|
| |
Options for Salvage Therapy for Myeloma Patients
Mohamad A. Hussein, MD
Cleveland Clinic Multiple Myeloma Program, Cleveland, OH
|
|
|
| |
Novel Immunomodulatory Therapies in the Treatment of Multiple Myeloma
Kenneth C. Anderson, MD
Dana-Farber Cancer Institute, Boston, MA
|
|
|
| |
The Refractory Patient: New Treatment Options
Michael W. Schuster, MD
Weill Medical College of Cornell University, New York, NY
|
|
|
| |
Prognostic Indicators for the Diagnosis of Multiple Myeloma
Philip Greipp, MD
Mayo Clinic, Rochester, MN
|
|
|
| |
Supportive Therapies in the Management of Myeloma
Heinz Ludwig, MD
Wilhelminenspital, Vienna, Austria
|
|
|
| |
Treatment Strategies for Myeloma Bone Disease
James R. Berenson, MD
Cedars-Sinai Medical Center, Los Angeles, CA
|
|
|
| |
Novel Strategies in the Treatment of Relapsed/Refractory Multiple Myeloma
Paul Richardson, MD
Dana-Farber Cancer Institute, Boston, MA
|
|
|
| |
Strategies in Treating Newly Diagnosed or Untreated Multiple Myeloma Patients
Donna Weber, MD
The University of Texas M.D. Anderson Cancer Center, Houston TX
|
|
|
|
|
|
|
|
|
Back to top
|
Supported by unrestricted educational grants from:
|
|
|
|
| | |
